Skip to main content
Erschienen in: Heart Failure Reviews 1/2012

01.01.2012

Heart failure, diastolic dysfunction and atrial fibrillation; mechanistic insight of a complex inter-relationship

verfasst von: J. C. Caldwell, M. A. Mamas

Erschienen in: Heart Failure Reviews | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Atrial fibrillation (AF) and heart failure (HF) commonly coexist, and their co-presence is associated with adverse outcomes relating to thromboembolic events, HF progression, hospitalisation and death. Diastolic dysfunction (DD) is also frequently present in patients with HF and is an independent predictor of hospitalisation and mortality. The presence of DD is a strong predictor of incident AF in patients with HF. In this review, we provide mechanistic insight into pathophysiological processes that frequently promote the occurrence of AF, HF and DD and outline the yin-yang relationship between AF, DD and HF. More recently, invasive studies have also shown that asymptomatic paroxysmal atrial fibrillation (PAF) is a common phenomenon in HF patients. We examine complex inter-relationships between PAF, HF and DD and speculate upon the possible clinical influence of undiagnosed PAF in HF patients.
Literatur
1.
Zurück zum Zitat Murphy NF, Simpson CR, Jhund PS, Stewart S, Kirkpatrick M, Chalmers J, MacIntyre K, McMurray JJV (2007) A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland. Heart 93:606–612PubMedCrossRef Murphy NF, Simpson CR, Jhund PS, Stewart S, Kirkpatrick M, Chalmers J, MacIntyre K, McMurray JJV (2007) A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland. Heart 93:606–612PubMedCrossRef
2.
Zurück zum Zitat Heeringa J, van der Kuip DAM, Hofman A, Kors JA, van Herpen G, Stricker BHC, Stijnen T, Lip GYH, Witteman JCM (2006) Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 27:949–953PubMedCrossRef Heeringa J, van der Kuip DAM, Hofman A, Kors JA, van Herpen G, Stricker BHC, Stijnen T, Lip GYH, Witteman JCM (2006) Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 27:949–953PubMedCrossRef
3.
Zurück zum Zitat Bleumink GS, Knetsch AM, Sturkenboom MC, Straus SM, Hofman A, Deckers JW, Witteman JC, Stricker BH (2004) Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure the Rotterdam study. Eur Heart J 25:1614–1619PubMedCrossRef Bleumink GS, Knetsch AM, Sturkenboom MC, Straus SM, Hofman A, Deckers JW, Witteman JC, Stricker BH (2004) Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure the Rotterdam study. Eur Heart J 25:1614–1619PubMedCrossRef
4.
Zurück zum Zitat Maisel WH, Stevenson LW (2003) Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol 91:2–8CrossRef Maisel WH, Stevenson LW (2003) Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol 91:2–8CrossRef
5.
Zurück zum Zitat Savelieva I, John Camm A (2003) Atrial fibrillation and heart failure: natural history and pharmacological treatment. Europace 5:S5–19CrossRef Savelieva I, John Camm A (2003) Atrial fibrillation and heart failure: natural history and pharmacological treatment. Europace 5:S5–19CrossRef
6.
Zurück zum Zitat Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW (1998) Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. J Am Coll Cardiol 32:695–703PubMedCrossRef Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW (1998) Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. J Am Coll Cardiol 32:695–703PubMedCrossRef
7.
Zurück zum Zitat Pedersen OD, Bagger H, Keller N, Marchant B, Kober L, Torp-Pedersen C (2001) Efficacy of Dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigation of arrhythmia and mortality on dofetilide (DIAMOND) sub study. Circulation 104:292–296PubMed Pedersen OD, Bagger H, Keller N, Marchant B, Kober L, Torp-Pedersen C (2001) Efficacy of Dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigation of arrhythmia and mortality on dofetilide (DIAMOND) sub study. Circulation 104:292–296PubMed
8.
Zurück zum Zitat Rivero-Ayerza M, Scholte op Reimer W, Lenzen M, Theuns DAMJ, Jordaens L, Komajda M, Follath F, Swedberg K, Cleland JGF (2008) New-onset atrial fibrillation is an independent predictor of in-hospital mortality in hospitalized heart failure patients: results of the Euro heart failure survey. Eur Heart J 29:1618–1624PubMedCrossRef Rivero-Ayerza M, Scholte op Reimer W, Lenzen M, Theuns DAMJ, Jordaens L, Komajda M, Follath F, Swedberg K, Cleland JGF (2008) New-onset atrial fibrillation is an independent predictor of in-hospital mortality in hospitalized heart failure patients: results of the Euro heart failure survey. Eur Heart J 29:1618–1624PubMedCrossRef
9.
Zurück zum Zitat Shelton RJ, Clark AL, Kaye GC, Cleland JG (2010) The atrial fibrillation paradox of heart failure. Congest Heart Fail 16:3–9PubMedCrossRef Shelton RJ, Clark AL, Kaye GC, Cleland JG (2010) The atrial fibrillation paradox of heart failure. Congest Heart Fail 16:3–9PubMedCrossRef
10.
Zurück zum Zitat Mamas MA, Caldwell JC, Chacko S, Garratt CJ, Fath-Ordoubadi F, Neyses L (2009) A meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure. Eur J Heart Fail 11:676–683PubMedCrossRef Mamas MA, Caldwell JC, Chacko S, Garratt CJ, Fath-Ordoubadi F, Neyses L (2009) A meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure. Eur J Heart Fail 11:676–683PubMedCrossRef
11.
Zurück zum Zitat Dini FL, Whalley G, Poppe K, Fontanive P, Rosa GM, Doughty RN, Di B, Di Bello V (2009) Plasma N-terminal pro type-B natriuretic peptide and restrictive mitral flow to risk-stratify patients with stage B heart failure. Clin Cardiol 32:711–717PubMedCrossRef Dini FL, Whalley G, Poppe K, Fontanive P, Rosa GM, Doughty RN, Di B, Di Bello V (2009) Plasma N-terminal pro type-B natriuretic peptide and restrictive mitral flow to risk-stratify patients with stage B heart failure. Clin Cardiol 32:711–717PubMedCrossRef
12.
Zurück zum Zitat Bruch C, Gotzmann M, Stypmann J, Wenzelburger F, Rothenburger M, Grude M, Scheld HH, Eckardt L, Breithardt G, Wichter T (2005) Electrocardiography and Doppler echocardiography for risk stratification in patients with chronic heart failure: incremental prognostic value of QRS duration and a restrictive mitral filling pattern. J Am Coll Cardiol 45:1072–1075PubMedCrossRef Bruch C, Gotzmann M, Stypmann J, Wenzelburger F, Rothenburger M, Grude M, Scheld HH, Eckardt L, Breithardt G, Wichter T (2005) Electrocardiography and Doppler echocardiography for risk stratification in patients with chronic heart failure: incremental prognostic value of QRS duration and a restrictive mitral filling pattern. J Am Coll Cardiol 45:1072–1075PubMedCrossRef
13.
Zurück zum Zitat Gardin JM, Leifer ES, Fleg JL, Whellan D, Kokkinos P, Leblanc MH, Wolfel E, Kitzman DW (2009) Relationship of Doppler-Echocardiographic left ventricular diastolic function to exercise performance in systolic heart failure: the HF-ACTION study. Am Heart J 158:S45–S52PubMedCrossRef Gardin JM, Leifer ES, Fleg JL, Whellan D, Kokkinos P, Leblanc MH, Wolfel E, Kitzman DW (2009) Relationship of Doppler-Echocardiographic left ventricular diastolic function to exercise performance in systolic heart failure: the HF-ACTION study. Am Heart J 158:S45–S52PubMedCrossRef
14.
Zurück zum Zitat Hamdan A, Shapira Y, Bengal T, Mansur M, Vaturi M, Sulkes J, Battler A, Sagie A (2006) Tissue Doppler imaging in patients with advanced heart failure: relation to functional class and prognosis. J Heart Lung Transplant 25:214–218PubMedCrossRef Hamdan A, Shapira Y, Bengal T, Mansur M, Vaturi M, Sulkes J, Battler A, Sagie A (2006) Tissue Doppler imaging in patients with advanced heart failure: relation to functional class and prognosis. J Heart Lung Transplant 25:214–218PubMedCrossRef
15.
Zurück zum Zitat Ren X, Ristow B, Na B, Ali S, Schiller NB, Whooley MA (2007) Prevalence and prognosis of asymptomatic left ventricular diastolic dysfunction in ambulatory patients with coronary heart disease. Am J Cardiol 99:1643–1647PubMedCrossRef Ren X, Ristow B, Na B, Ali S, Schiller NB, Whooley MA (2007) Prevalence and prognosis of asymptomatic left ventricular diastolic dysfunction in ambulatory patients with coronary heart disease. Am J Cardiol 99:1643–1647PubMedCrossRef
16.
Zurück zum Zitat Tsang TSM, Barnes ME, Gersh BJ, Bailey KR, Seward JB (2004) Risks for atrial fibrillation and congestive heart failure in patients ≥ 65 years of age with abnormal left ventricular diastolic relaxation. Am J Cardiol 93:54–58PubMedCrossRef Tsang TSM, Barnes ME, Gersh BJ, Bailey KR, Seward JB (2004) Risks for atrial fibrillation and congestive heart failure in patients ≥ 65 years of age with abnormal left ventricular diastolic relaxation. Am J Cardiol 93:54–58PubMedCrossRef
17.
Zurück zum Zitat From AM, Scott CG, Chen HH (2010) The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction: a population-based study. J Am Coll Cardiol 55:300–305PubMedCrossRef From AM, Scott CG, Chen HH (2010) The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction: a population-based study. J Am Coll Cardiol 55:300–305PubMedCrossRef
18.
Zurück zum Zitat Okura H, Takada Y, Kubo T, Iwata K, Mizoguchi S, Taguchi H, Toda I, Yoshikawa J, Yoshida K (2006) Tissue Doppler-derived index of left ventricular filling pressure, E/EΓǦ, predicts survival of patients with non-valvular atrial fibrillation. Heart 92:1248–1252PubMedCrossRef Okura H, Takada Y, Kubo T, Iwata K, Mizoguchi S, Taguchi H, Toda I, Yoshikawa J, Yoshida K (2006) Tissue Doppler-derived index of left ventricular filling pressure, E/EΓǦ, predicts survival of patients with non-valvular atrial fibrillation. Heart 92:1248–1252PubMedCrossRef
19.
Zurück zum Zitat Schotten U, Neuberger HR, Allessie MA (2003) The role of atrial dilatation in the domestication of atrial fibrillation. Prog Biophys Mol Biol 82:151–162PubMedCrossRef Schotten U, Neuberger HR, Allessie MA (2003) The role of atrial dilatation in the domestication of atrial fibrillation. Prog Biophys Mol Biol 82:151–162PubMedCrossRef
20.
Zurück zum Zitat Zou R, Kneller J, Leon JL, Nattel S (2005) Substrate size as a determinant of fibrillatory activity maintenance in a mathematical model of canine atrium. Am J Physiol Heart Circ Physiol 00252 Zou R, Kneller J, Leon JL, Nattel S (2005) Substrate size as a determinant of fibrillatory activity maintenance in a mathematical model of canine atrium. Am J Physiol Heart Circ Physiol 00252
21.
Zurück zum Zitat Zhang YH, Youm JB, Sung HK, Lee SH, Ryu SY, Ho WK, Earm YE (2000) Stretch-activated and background non-selective cation channels in rat atrial myocytes. J Physiol 523(Pt 3):607–619PubMedCrossRef Zhang YH, Youm JB, Sung HK, Lee SH, Ryu SY, Ho WK, Earm YE (2000) Stretch-activated and background non-selective cation channels in rat atrial myocytes. J Physiol 523(Pt 3):607–619PubMedCrossRef
22.
Zurück zum Zitat Niu W, Sachs F (2003) Dynamic properties of stretch-activated K + channels in adult rat atrial myocytes. Prog Biophys Mol Biol 82:121–135PubMedCrossRef Niu W, Sachs F (2003) Dynamic properties of stretch-activated K + channels in adult rat atrial myocytes. Prog Biophys Mol Biol 82:121–135PubMedCrossRef
23.
Zurück zum Zitat Tomaselli GF, Marban E (1999) Electrophysiological remodelings in hypertrophy and heart failure. Cardiovasc Res 42:270–283PubMedCrossRef Tomaselli GF, Marban E (1999) Electrophysiological remodelings in hypertrophy and heart failure. Cardiovasc Res 42:270–283PubMedCrossRef
24.
Zurück zum Zitat Solti F, Vecsey T, Kekesi V, Juhasz-Nagy A (1989) The effect of atrial dilatation on the genesis of atrial arrhythmias. Cardiovasc Res 23:882–886PubMedCrossRef Solti F, Vecsey T, Kekesi V, Juhasz-Nagy A (1989) The effect of atrial dilatation on the genesis of atrial arrhythmias. Cardiovasc Res 23:882–886PubMedCrossRef
25.
Zurück zum Zitat Tisdale JE, Borzak S, Sabbah HN, Shimoyama H, Goldstein S (2006) Hemodynamic and neurohormonal predictors and consequences of the development of atrial fibrillation in dogs with chronic heart failure. J Card Fail 12:747–751PubMedCrossRef Tisdale JE, Borzak S, Sabbah HN, Shimoyama H, Goldstein S (2006) Hemodynamic and neurohormonal predictors and consequences of the development of atrial fibrillation in dogs with chronic heart failure. J Card Fail 12:747–751PubMedCrossRef
26.
Zurück zum Zitat Van den Berg MP, Cruns HJ, Van Veldhuisen DJ, Griep N, De Kam PJ, Lie KI (1995) Effects of lisinopril in patients with heart failure and chronic atrial fibrillation. J Card Fail 1:355–363CrossRef Van den Berg MP, Cruns HJ, Van Veldhuisen DJ, Griep N, De Kam PJ, Lie KI (1995) Effects of lisinopril in patients with heart failure and chronic atrial fibrillation. J Card Fail 1:355–363CrossRef
27.
Zurück zum Zitat Zhang LM, Wang Z, Nattel S (2002) Effects of sustained beta-adrenergic stimulation on ionic currents of cultured adult guinea pig cardiomyocytes. Am J Physiol Heart Circ Physiol 282:H880–H889PubMed Zhang LM, Wang Z, Nattel S (2002) Effects of sustained beta-adrenergic stimulation on ionic currents of cultured adult guinea pig cardiomyocytes. Am J Physiol Heart Circ Physiol 282:H880–H889PubMed
28.
Zurück zum Zitat Sridhar A, Nishijima Y, Terentyev D, Khan M, Terentyeva R, Hamlin RL, Nakayama T, Gyorke S, Cardounel AJ, Carnes CA (2009) Chronic heart failure and the substrate for atrial fibrillation. Cardiovasc Res 84:227–236PubMedCrossRef Sridhar A, Nishijima Y, Terentyev D, Khan M, Terentyeva R, Hamlin RL, Nakayama T, Gyorke S, Cardounel AJ, Carnes CA (2009) Chronic heart failure and the substrate for atrial fibrillation. Cardiovasc Res 84:227–236PubMedCrossRef
29.
Zurück zum Zitat Li D, Shinagawa K, Pang L, Leung TK, Cardin S, Wang Z, Nattel S (2001) Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation 104:2608–2614PubMedCrossRef Li D, Shinagawa K, Pang L, Leung TK, Cardin S, Wang Z, Nattel S (2001) Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation 104:2608–2614PubMedCrossRef
30.
Zurück zum Zitat Pedersen OD, Bagger H, Kober L, Torp-Pedersen C (1999) Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation 100:376–380PubMed Pedersen OD, Bagger H, Kober L, Torp-Pedersen C (1999) Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation 100:376–380PubMed
31.
Zurück zum Zitat Vermes E, Tardif JC, Bourassa MG, Racine N, Levesque S, White M, Guerra PG, Ducharme A (2003) Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the studies of left ventricular dysfunction (SOLVD) trials. Circulation 107:2926–2931PubMedCrossRef Vermes E, Tardif JC, Bourassa MG, Racine N, Levesque S, White M, Guerra PG, Ducharme A (2003) Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the studies of left ventricular dysfunction (SOLVD) trials. Circulation 107:2926–2931PubMedCrossRef
32.
Zurück zum Zitat Maggioni AP, Latini R, Carson PE, Singh SN, Barlera S, Glazer R, Masson S, Cere E, Tognoni G, Cohn JN (2005) Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the valsartan heart failure trial (Val-HeFT). Am Heart J 149:548–557PubMedCrossRef Maggioni AP, Latini R, Carson PE, Singh SN, Barlera S, Glazer R, Masson S, Cere E, Tognoni G, Cohn JN (2005) Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the valsartan heart failure trial (Val-HeFT). Am Heart J 149:548–557PubMedCrossRef
33.
Zurück zum Zitat Ducharme A, Swedberg K, Pfeffer MA, Cohen-Solal A, Granger CB, Maggioni AP, Michelson EL, McMurray JJV, Olsson L, Rouleau JL, Young JB, Olofsson B, Puu M, Yusuf S (2006) Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in heart failure: assessment of reduction in Mortality and morbidity (CHARM) program. Am Heart J152:86–92CrossRef Ducharme A, Swedberg K, Pfeffer MA, Cohen-Solal A, Granger CB, Maggioni AP, Michelson EL, McMurray JJV, Olsson L, Rouleau JL, Young JB, Olofsson B, Puu M, Yusuf S (2006) Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in heart failure: assessment of reduction in Mortality and morbidity (CHARM) program. Am Heart J152:86–92CrossRef
34.
Zurück zum Zitat Tsang TSM, Gersh BJ, Appleton CP, Tajik AJ, Barnes ME, Bailey KR, Oh JK, Leibson C, Montgomery SC, Seward JB (2002) Left ventricular diastolic dysfunction as a predictor of the first diagnosed non valvular atrial fibrillation in 840 elderly men and women. J AmColl Cardiol 40:1636–1644CrossRef Tsang TSM, Gersh BJ, Appleton CP, Tajik AJ, Barnes ME, Bailey KR, Oh JK, Leibson C, Montgomery SC, Seward JB (2002) Left ventricular diastolic dysfunction as a predictor of the first diagnosed non valvular atrial fibrillation in 840 elderly men and women. J AmColl Cardiol 40:1636–1644CrossRef
35.
Zurück zum Zitat Jons C, Moerch Joergensen R, Hassager C, Gang UJ, Dixen U, Johannesen A, Olsen NT, Hansen TF, Messier M, Huikuri HV, Bloch Thomsen PE (2010) Diastolic dysfunction predicts new-onset atrial fibrillation and cardiovascular events in patients with acute myocardial infarction and depressed left ventricular systolic function: a CARISMA substudy. Eur J Echocard 11:602–607CrossRef Jons C, Moerch Joergensen R, Hassager C, Gang UJ, Dixen U, Johannesen A, Olsen NT, Hansen TF, Messier M, Huikuri HV, Bloch Thomsen PE (2010) Diastolic dysfunction predicts new-onset atrial fibrillation and cardiovascular events in patients with acute myocardial infarction and depressed left ventricular systolic function: a CARISMA substudy. Eur J Echocard 11:602–607CrossRef
36.
Zurück zum Zitat Celik S, Erdol C, Baykan M, Kaplan S, Kasap H (2001) Relation between paroxysmal atrial fibrillation and left ventricular diastolic function in patients with acute myocardial infarction. Am J Cardiol 88:160–162PubMedCrossRef Celik S, Erdol C, Baykan M, Kaplan S, Kasap H (2001) Relation between paroxysmal atrial fibrillation and left ventricular diastolic function in patients with acute myocardial infarction. Am J Cardiol 88:160–162PubMedCrossRef
37.
Zurück zum Zitat Tukek T, Yildiz P, Akkaya V, Karan MA, Atilgan D, Yilmaz V, Korkut F (2002) Factors associated with the development of atrial fibrillation in COPD patients: the role of P-wave dispersion. Ann Noninvasive Electrocardiol 7:222–227PubMedCrossRef Tukek T, Yildiz P, Akkaya V, Karan MA, Atilgan D, Yilmaz V, Korkut F (2002) Factors associated with the development of atrial fibrillation in COPD patients: the role of P-wave dispersion. Ann Noninvasive Electrocardiol 7:222–227PubMedCrossRef
38.
Zurück zum Zitat Vranka I, Penz P, Dukat A (2007) Atrial conduction delay and its association with left atrial dimension, left atrial pressure and left ventricular diastolic dysfunction in patients at risk of atrial fibrillation. Exp Clin Cardiol 12:197–201PubMed Vranka I, Penz P, Dukat A (2007) Atrial conduction delay and its association with left atrial dimension, left atrial pressure and left ventricular diastolic dysfunction in patients at risk of atrial fibrillation. Exp Clin Cardiol 12:197–201PubMed
39.
Zurück zum Zitat Sun H, Chartier D, Leblanc N, Nattel S (2001) Intracellular calcium changes and tachycardia-induced contractile dysfunction in canine atrial myocytes. Cardiovasc Res 49:751–761PubMedCrossRef Sun H, Chartier D, Leblanc N, Nattel S (2001) Intracellular calcium changes and tachycardia-induced contractile dysfunction in canine atrial myocytes. Cardiovasc Res 49:751–761PubMedCrossRef
40.
Zurück zum Zitat Balijepalli RC, Lokuta AJ, Maertz NA, Buck JM, Haworth RA, Valdivia HH, Kamp TJ (2003) Depletion of T-tubules and specific subcellular changes in sarcolemmal proteins in tachycardia-induced heart failure. Cardiovasc Res 59:67–77PubMedCrossRef Balijepalli RC, Lokuta AJ, Maertz NA, Buck JM, Haworth RA, Valdivia HH, Kamp TJ (2003) Depletion of T-tubules and specific subcellular changes in sarcolemmal proteins in tachycardia-induced heart failure. Cardiovasc Res 59:67–77PubMedCrossRef
41.
Zurück zum Zitat Naito M, David D, Michelson EL, Schaffenburg M, Dreifus LS (1983) The hemodynamic consequences of cardiac arrhythmias: evaluation of the relative roles of abnormal atrioventricular sequencing, irregularity of ventricular rhythm and atrial fibrillation in a canine model. Am Heart J 106:284–291PubMedCrossRef Naito M, David D, Michelson EL, Schaffenburg M, Dreifus LS (1983) The hemodynamic consequences of cardiac arrhythmias: evaluation of the relative roles of abnormal atrioventricular sequencing, irregularity of ventricular rhythm and atrial fibrillation in a canine model. Am Heart J 106:284–291PubMedCrossRef
42.
Zurück zum Zitat Clark DM, Plumb VJ, Epstein AE, Kay GN (1997) Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol 30:1039–1045PubMedCrossRef Clark DM, Plumb VJ, Epstein AE, Kay GN (1997) Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol 30:1039–1045PubMedCrossRef
43.
Zurück zum Zitat Pozzoli M, Cioffi G, Traversi E, Pinna GD, Cobelli F, Tavazzi L (1998) Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm. J Am Coll Cardiol 32:197–204PubMedCrossRef Pozzoli M, Cioffi G, Traversi E, Pinna GD, Cobelli F, Tavazzi L (1998) Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm. J Am Coll Cardiol 32:197–204PubMedCrossRef
44.
Zurück zum Zitat Byrne M, Kaye DM, Power J (2008) The synergism between atrial fibrillation and heart failure. J CardFail 14:320–326 Byrne M, Kaye DM, Power J (2008) The synergism between atrial fibrillation and heart failure. J CardFail 14:320–326
45.
Zurück zum Zitat Hagens VE, Van Veldhuisen DJ, Kamp O, Rienstra M, Bosker HA, Veeger NJGM, Tijssen JGP, Crijns HJGM, Van Gelder IC (2005) Effect of rate and rhythm control on left ventricular function and cardiac dimensions in patients with persistent atrial fibrillation: results from the rate control versus electrical cardio version for persistent atrial fibrillation (RACE) study. Heart Rhythm 2:19–24PubMedCrossRef Hagens VE, Van Veldhuisen DJ, Kamp O, Rienstra M, Bosker HA, Veeger NJGM, Tijssen JGP, Crijns HJGM, Van Gelder IC (2005) Effect of rate and rhythm control on left ventricular function and cardiac dimensions in patients with persistent atrial fibrillation: results from the rate control versus electrical cardio version for persistent atrial fibrillation (RACE) study. Heart Rhythm 2:19–24PubMedCrossRef
46.
Zurück zum Zitat Kosior DA, Stawicki S, Wozakowska-Kaplon B, Szulc M, Opolski G, Rabczenko D (2005) Impact of sinus rhythm restoration and maintenance on left ventricular function and exercise tolerance in patients with persistent atrial fibrillation. Kardiol Pol 63:36–47PubMed Kosior DA, Stawicki S, Wozakowska-Kaplon B, Szulc M, Opolski G, Rabczenko D (2005) Impact of sinus rhythm restoration and maintenance on left ventricular function and exercise tolerance in patients with persistent atrial fibrillation. Kardiol Pol 63:36–47PubMed
47.
Zurück zum Zitat Hsu LF, Jais P, Sanders P, Garrigue S, Hocini M, Sacher F, Takahashi Y, Rotter M, Pasquie JL, Scavee C, Bordachar P, Clementy J, Haissaguerre M (2004) Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 351:2373–2383PubMedCrossRef Hsu LF, Jais P, Sanders P, Garrigue S, Hocini M, Sacher F, Takahashi Y, Rotter M, Pasquie JL, Scavee C, Bordachar P, Clementy J, Haissaguerre M (2004) Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 351:2373–2383PubMedCrossRef
48.
Zurück zum Zitat Lutomsky BA, Rostock T, Koops A, Steven D, Mullerleile K, Servatius H, Drewitz I, Ueberschar D, Plagemann T, Ventura R, Meinertz T, Willems S (2008) Catheter ablation of paroxysmal atrial fibrillation improves cardiac function: a prospective study on the impact of atrial fibrillation ablation on left ventricular function assessed by magnetic resonance imaging. Europace 10:593–599PubMedCrossRef Lutomsky BA, Rostock T, Koops A, Steven D, Mullerleile K, Servatius H, Drewitz I, Ueberschar D, Plagemann T, Ventura R, Meinertz T, Willems S (2008) Catheter ablation of paroxysmal atrial fibrillation improves cardiac function: a prospective study on the impact of atrial fibrillation ablation on left ventricular function assessed by magnetic resonance imaging. Europace 10:593–599PubMedCrossRef
49.
Zurück zum Zitat Aronow WS, Ahn C, Kronzon I (2001) Prognosis of congestive heart failure after prior myocardial infarction in older persons with atrial fibrillation versus sinus rhythm. Am J Cardiol 87:224–225PubMedCrossRef Aronow WS, Ahn C, Kronzon I (2001) Prognosis of congestive heart failure after prior myocardial infarction in older persons with atrial fibrillation versus sinus rhythm. Am J Cardiol 87:224–225PubMedCrossRef
50.
Zurück zum Zitat Olsson LG, Swedberg K, Ducharme A, Granger CB, Michelson EL, McMurray JJV, Puu M, Yusuf S, Pfeffer MA (2006) Atrial Fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the candesartan in heart failure-assessment of reduction in mortality and morbidity (CHARM) program. J Am Coll Cardiol 47:1997–2004PubMedCrossRef Olsson LG, Swedberg K, Ducharme A, Granger CB, Michelson EL, McMurray JJV, Puu M, Yusuf S, Pfeffer MA (2006) Atrial Fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the candesartan in heart failure-assessment of reduction in mortality and morbidity (CHARM) program. J Am Coll Cardiol 47:1997–2004PubMedCrossRef
51.
Zurück zum Zitat Mathew J, Hunsberger S, Fleg J, Mc Sherry F, Williford W, Yusuf S (2000) Incidence, predictive factors, and prognostic significance of supraventricular tachyarrhythmia’s in congestive heart failure. Chest 118:914–922PubMedCrossRef Mathew J, Hunsberger S, Fleg J, Mc Sherry F, Williford W, Yusuf S (2000) Incidence, predictive factors, and prognostic significance of supraventricular tachyarrhythmia’s in congestive heart failure. Chest 118:914–922PubMedCrossRef
52.
Zurück zum Zitat Zareba W, Steinberg JS, McNitt S, Daubert JP, Piotrowicz K, Moss AJ (2006) Implantable cardioverter-defibrillator therapy and risk of congestive heart failure or death in MADIT II patients with atrial fibrillation. Heart Rhythm 3:631–637PubMedCrossRef Zareba W, Steinberg JS, McNitt S, Daubert JP, Piotrowicz K, Moss AJ (2006) Implantable cardioverter-defibrillator therapy and risk of congestive heart failure or death in MADIT II patients with atrial fibrillation. Heart Rhythm 3:631–637PubMedCrossRef
53.
Zurück zum Zitat Swedberg K, Olsson LG, Charlesworth A, Cleland J, Hanrath P, Komajda M, Metra M, Torp-Pedersen C, Poole-Wilson P (2005) Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET. Eur Heart J 26:1303–1308PubMedCrossRef Swedberg K, Olsson LG, Charlesworth A, Cleland J, Hanrath P, Komajda M, Metra M, Torp-Pedersen C, Poole-Wilson P (2005) Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET. Eur Heart J 26:1303–1308PubMedCrossRef
54.
Zurück zum Zitat Corell P, Gustafsson F, Schou M, Markenvard J, Nielsen T, Hildebrandt P (2007) Prevalence and prognostic significance of atrial fibrillation in outpatients with heart failure due to left ventricular systolic dysfunction. Eur J Heart Fail 9:258–265PubMedCrossRef Corell P, Gustafsson F, Schou M, Markenvard J, Nielsen T, Hildebrandt P (2007) Prevalence and prognostic significance of atrial fibrillation in outpatients with heart failure due to left ventricular systolic dysfunction. Eur J Heart Fail 9:258–265PubMedCrossRef
55.
Zurück zum Zitat Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, D’Agostino RB, Murabito JM, Kannel WB, Benjamin EJ (2003) Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham heart study. Circulation 107:2920–2925PubMedCrossRef Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, D’Agostino RB, Murabito JM, Kannel WB, Benjamin EJ (2003) Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham heart study. Circulation 107:2920–2925PubMedCrossRef
56.
Zurück zum Zitat Middlekauff HR, Stevenson WG, Stevenson LW (1991) Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation 84:40–48PubMed Middlekauff HR, Stevenson WG, Stevenson LW (1991) Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation 84:40–48PubMed
57.
Zurück zum Zitat Pedersen OD, Brendorp B, Elming H, Pehrson S, Kber L, Torp-Pedersen C (2003) Does conversion and prevention of atrial fibrillation enhance survival in patients with left ventricular dysfunction? Evidence from the Danish investigations of arrhythmia and mortality on dofetilide/(DIAMOND) study card. Electrophys Rev 7:220–224CrossRef Pedersen OD, Brendorp B, Elming H, Pehrson S, Kber L, Torp-Pedersen C (2003) Does conversion and prevention of atrial fibrillation enhance survival in patients with left ventricular dysfunction? Evidence from the Danish investigations of arrhythmia and mortality on dofetilide/(DIAMOND) study card. Electrophys Rev 7:220–224CrossRef
58.
Zurück zum Zitat Ahmed A, Thornton P, Perry GJ, Allman RM, DeLong JF (2004) Impact of atrial fibrillation on mortality and readmission in older adults hospitalized with heart failure. Eur J Heart Fail 6:421–426PubMedCrossRef Ahmed A, Thornton P, Perry GJ, Allman RM, DeLong JF (2004) Impact of atrial fibrillation on mortality and readmission in older adults hospitalized with heart failure. Eur J Heart Fail 6:421–426PubMedCrossRef
59.
Zurück zum Zitat Pai RG, Varadarajan P (2007) Prognostic significance of atrial fibrillation is a function of left ventricular ejection fraction. Clin Cardiol 30:349–354PubMedCrossRef Pai RG, Varadarajan P (2007) Prognostic significance of atrial fibrillation is a function of left ventricular ejection fraction. Clin Cardiol 30:349–354PubMedCrossRef
60.
Zurück zum Zitat Crijns HJGM, Tjeerdsma G, de Kam PJ, Boomsma F, Van Gelder IC, van den Berg MP, van Veldhuisen DJ (2000) Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure. Eur Heart J 21:1238–1245PubMedCrossRef Crijns HJGM, Tjeerdsma G, de Kam PJ, Boomsma F, Van Gelder IC, van den Berg MP, van Veldhuisen DJ (2000) Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure. Eur Heart J 21:1238–1245PubMedCrossRef
61.
Zurück zum Zitat Carson PE, Johnson GR, Dunkman WB, Fletcher RD, Farrell L, Cohn JN (1993) The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT studies. The V-HeFT VA cooperative studies group. Circulation 87:VI102–VI110PubMed Carson PE, Johnson GR, Dunkman WB, Fletcher RD, Farrell L, Cohn JN (1993) The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT studies. The V-HeFT VA cooperative studies group. Circulation 87:VI102–VI110PubMed
62.
Zurück zum Zitat Mahoney P, Kimmel S, DeNofrio D, Wahl P, Loh E (1999) Prognostic significance of atrial fibrillation in patients at a tertiary medical centre referred for heart transplantation because of severe heart failure. Am J Cardiol 83:1544–1547PubMedCrossRef Mahoney P, Kimmel S, DeNofrio D, Wahl P, Loh E (1999) Prognostic significance of atrial fibrillation in patients at a tertiary medical centre referred for heart transplantation because of severe heart failure. Am J Cardiol 83:1544–1547PubMedCrossRef
63.
Zurück zum Zitat Stevenson WG, Stevenson LW, Fonarow GC, Middlekauff HR, Hamilton MA, Woo MA, Saxon LA, Natterson PD, Steimle A, Walden JA, Tillisch JH (1996) Improving survival for patients with atrial fibrillation and advanced heart failure. J Am Coll Cardiol 28:1458–1463PubMedCrossRef Stevenson WG, Stevenson LW, Fonarow GC, Middlekauff HR, Hamilton MA, Woo MA, Saxon LA, Natterson PD, Steimle A, Walden JA, Tillisch JH (1996) Improving survival for patients with atrial fibrillation and advanced heart failure. J Am Coll Cardiol 28:1458–1463PubMedCrossRef
64.
Zurück zum Zitat Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL, Bourassa MG, Arnold JM, Buxton AE, Camm AJ, Connolly SJ, Dubuc M, Ducharme A, Guerra PG, Hohnloser SH, Lambert J, Le Heuzey JY, O’Hara G, Pedersen OD, Rouleau JL, Singh BN, Stevenson LW, Stevenson WG, Thibault B, Waldo AL, The Atrial Fibrillation, Congestive Heart Failure Investigators (2008) Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 358:2667–2677PubMedCrossRef Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL, Bourassa MG, Arnold JM, Buxton AE, Camm AJ, Connolly SJ, Dubuc M, Ducharme A, Guerra PG, Hohnloser SH, Lambert J, Le Heuzey JY, O’Hara G, Pedersen OD, Rouleau JL, Singh BN, Stevenson LW, Stevenson WG, Thibault B, Waldo AL, The Atrial Fibrillation, Congestive Heart Failure Investigators (2008) Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 358:2667–2677PubMedCrossRef
65.
Zurück zum Zitat Fung JWH, Yip GWK, Zhang Q, Fang F, Chan JYS, Li CM, Wu LW, Chan GCP, Chan HCK, Yu CM (2008) Improvement of left atrial function is associated with lower incidence of atrial fibrillation and mortality after cardiac resynchronization therapy. Heart Rhythm 5:780–786PubMedCrossRef Fung JWH, Yip GWK, Zhang Q, Fang F, Chan JYS, Li CM, Wu LW, Chan GCP, Chan HCK, Yu CM (2008) Improvement of left atrial function is associated with lower incidence of atrial fibrillation and mortality after cardiac resynchronization therapy. Heart Rhythm 5:780–786PubMedCrossRef
66.
Zurück zum Zitat Lee SH, Choi S, Chung WJ, Byun YS, Ryu SK, Pyun WB, Rim SJ (2008) Tissue Doppler index, E/E’, and ischemic stroke in patients with atrial fibrillation and preserved left ventricular ejection fraction. J Neuro Sc 271:148–152CrossRef Lee SH, Choi S, Chung WJ, Byun YS, Ryu SK, Pyun WB, Rim SJ (2008) Tissue Doppler index, E/E’, and ischemic stroke in patients with atrial fibrillation and preserved left ventricular ejection fraction. J Neuro Sc 271:148–152CrossRef
67.
Zurück zum Zitat Tabata T, Grimm RA, Asada J, Popovic ZB, Yamada H, Greenberg NL, Wallick DW, Zhang Y, Zhuang S, Mowrey KA, Thomas JD, Mazgalev TN (2004) Determinants of LV diastolic function during atrial fibrillation: beat-to-beat analysis in acute dog experiments. Am J Physiol Heart Circ Physiol 286:H145–H152PubMedCrossRef Tabata T, Grimm RA, Asada J, Popovic ZB, Yamada H, Greenberg NL, Wallick DW, Zhang Y, Zhuang S, Mowrey KA, Thomas JD, Mazgalev TN (2004) Determinants of LV diastolic function during atrial fibrillation: beat-to-beat analysis in acute dog experiments. Am J Physiol Heart Circ Physiol 286:H145–H152PubMedCrossRef
68.
Zurück zum Zitat Yu CM, Wang Q, Lau CP, Tse HF, Leung SK, Lee KL, Tsang V, Ayers G (2001) Reversible impairment of left and right ventricular systolic and diastolic function during short-lasting atrial fibrillation in patients with an implantable atrial defibrillator: a tissue Doppler imaging study. Pacing Clin Electrophysiol 24:979–988PubMedCrossRef Yu CM, Wang Q, Lau CP, Tse HF, Leung SK, Lee KL, Tsang V, Ayers G (2001) Reversible impairment of left and right ventricular systolic and diastolic function during short-lasting atrial fibrillation in patients with an implantable atrial defibrillator: a tissue Doppler imaging study. Pacing Clin Electrophysiol 24:979–988PubMedCrossRef
69.
Zurück zum Zitat Wijffels MCEF, Kirchhof CJHJ, Dorland R, Allessie MA (1995) Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation 92:1954–1968PubMed Wijffels MCEF, Kirchhof CJHJ, Dorland R, Allessie MA (1995) Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation 92:1954–1968PubMed
70.
Zurück zum Zitat LIP GY, Lim HS (2000) Asymptomatic atrial fibrillation on device interrogation. J Cardiovasc Electrophysiol 19:891–893 LIP GY, Lim HS (2000) Asymptomatic atrial fibrillation on device interrogation. J Cardiovasc Electrophysiol 19:891–893
71.
Zurück zum Zitat Li D, Fareh S, Leung TK, Nattel S (1999) Promotion of atrial fibrillation by heart failure in dogs: atrial remodelling of a different sort. Circulation 100:87–95PubMed Li D, Fareh S, Leung TK, Nattel S (1999) Promotion of atrial fibrillation by heart failure in dogs: atrial remodelling of a different sort. Circulation 100:87–95PubMed
72.
Zurück zum Zitat Cardin S, Li D, Thorin-Trescases N, Leung TK, Thorin E, Nattel S (2003) Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways. Cardiovasc Res 60:315–325PubMedCrossRef Cardin S, Li D, Thorin-Trescases N, Leung TK, Thorin E, Nattel S (2003) Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways. Cardiovasc Res 60:315–325PubMedCrossRef
73.
Zurück zum Zitat Caldwell JC, Contractor H, Petkar S, Ali R, Clarke B, Garratt CJ, Neyses L, Mamas M (2009) Atrial fibrillation is under recognised in chronic heart failure—insights from a heart failure cohort treated with CRT therapy. Europace 11:1295–1300PubMedCrossRef Caldwell JC, Contractor H, Petkar S, Ali R, Clarke B, Garratt CJ, Neyses L, Mamas M (2009) Atrial fibrillation is under recognised in chronic heart failure—insights from a heart failure cohort treated with CRT therapy. Europace 11:1295–1300PubMedCrossRef
74.
Zurück zum Zitat Caldwell J, Mamas M, Garratt C, Neyses L (2008) How common is asymptomatic paroxysmal atrial fibrillation in chronic heart failure? Scand Cardiovasc J 18(1):1 Caldwell J, Mamas M, Garratt C, Neyses L (2008) How common is asymptomatic paroxysmal atrial fibrillation in chronic heart failure? Scand Cardiovasc J 18(1):1
75.
Zurück zum Zitat Sakabe K, Fukuda N, Fukuda Y, Morishita S, Shinohara H, Tamura Y (2009) Prediction of transition to chronic atrial fibrillation in elderly patients with non valvular paroxysmal atrial fibrillation by transthoracic Doppler echocardiography. Clin Cardiol 32:E23–E28PubMedCrossRef Sakabe K, Fukuda N, Fukuda Y, Morishita S, Shinohara H, Tamura Y (2009) Prediction of transition to chronic atrial fibrillation in elderly patients with non valvular paroxysmal atrial fibrillation by transthoracic Doppler echocardiography. Clin Cardiol 32:E23–E28PubMedCrossRef
76.
Zurück zum Zitat Koitabashi T, Inomata T, Niwano S, Nishii M, Takeuchi I, Nakano H, Shinagawa H, Takehana H, Izumi T (2005) Paroxysmal atrial fibrillation coincident with cardiac decompensation is a predictor of poor prognosis in chronic heart failure. Circ J 69:823–830PubMedCrossRef Koitabashi T, Inomata T, Niwano S, Nishii M, Takeuchi I, Nakano H, Shinagawa H, Takehana H, Izumi T (2005) Paroxysmal atrial fibrillation coincident with cardiac decompensation is a predictor of poor prognosis in chronic heart failure. Circ J 69:823–830PubMedCrossRef
77.
Zurück zum Zitat Puglisi A, Gaspini M, Lunati M, Sassara M, Padeletti L, Landolina M, Botto GL, Vincenti A, Bianchi S, Denaro A, Grammatico A, Boriani G (2000) Persistent atrial fibrillation worsens heart rate variability, activity and heart rate, as shown by a continuous monitoring by implantable biventricular pacemakers in heart failure patients. J Cardiovasc Electrophysiol 19:693–701CrossRef Puglisi A, Gaspini M, Lunati M, Sassara M, Padeletti L, Landolina M, Botto GL, Vincenti A, Bianchi S, Denaro A, Grammatico A, Boriani G (2000) Persistent atrial fibrillation worsens heart rate variability, activity and heart rate, as shown by a continuous monitoring by implantable biventricular pacemakers in heart failure patients. J Cardiovasc Electrophysiol 19:693–701CrossRef
Metadaten
Titel
Heart failure, diastolic dysfunction and atrial fibrillation; mechanistic insight of a complex inter-relationship
verfasst von
J. C. Caldwell
M. A. Mamas
Publikationsdatum
01.01.2012
Verlag
Springer US
Erschienen in
Heart Failure Reviews / Ausgabe 1/2012
Print ISSN: 1382-4147
Elektronische ISSN: 1573-7322
DOI
https://doi.org/10.1007/s10741-010-9204-4

Weitere Artikel der Ausgabe 1/2012

Heart Failure Reviews 1/2012 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.